TY - JOUR
T1 - Corrigendum to “Cellular landscaping of cisplatin resistance in cervical cancer” Biomed. Pharmacother. 153(2022) 113345 (Biomedicine & Pharmacotherapy (2022) 153, (S075333222200734X), (10.1016/j.biopha.2022.113345))
AU - Bhattacharjee, Rahul
AU - Dey, Tanima
AU - Kumar, Lamha
AU - Kar, Sulagna
AU - Sarkar, Ritayan
AU - Ghorai, Mimosa
AU - Malik, Sumira
AU - Jha, Niraj Kumar
AU - Vellingiri, Balachandar
AU - Kesari, Kavindra Kumar
AU - Pérez de la Lastra, José M.
AU - Dey, Abhijit
N1 - Publisher Copyright: © 2024 The Authors
PY - 2024/8
Y1 - 2024/8
N2 - The authors regret that incorrect information was given in the citation list of the publication The incorrect references and their corrections are as follows: Reference 27 should be same as reference 245 Reference 75 should be same as reference 82 Reference 274 should be same as reference 276 Reference 53 should be: Li, Q., Peng, X., Yang, H., Rodriguez, J. A., & Shu, Y. (2012). Contribution of organic cation transporter 3 to cisplatin cytotoxicity in human cervical cancer cells. Journal of pharmaceutical sciences, 101(1), 394–404. Reference 61 Should be: Waalkes, M. P., Liu, J., Kasprzak, K. S., & Diwan, B. A. (2006). Hypersusceptibility to cisplatin carcinogenicity in metallothionein-I/II double knockout mice: Production of hepatocellular carcinoma at clinically relevant doses. International journal of cancer, 119(1), 28–32. https://doi.org/10.1002/ijc.21245 References 69, and 73 should be: Wang, N., Hou, M. S., Zhan, Y., Shen, X. B., & Xue, H. Y. (2018). MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway. European Review for Medical & Pharmacological Sciences, 22(22). Reference 96 should be: Chen SH, Chang JY. New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment. Int J Mol Sci. 2019 Aug 24;20(17):4136. doi: 10.3390/ijms20174136 Reference 229 should be: O′Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018). Overview of microRNA biogenesis, mechanisms of actions, and circulation. Frontiers in endocrinology, 9, 402. Reference 247 should be: Schräder, M., Nayeri, S., Kahlen, J. P., Müller, K. M., & Carlberg, C. (1995). Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation. Molecular and cellular biology, 15(3), 1154–1161. References 4, 156, 180, 199, 270, 273, are unnecessary and can be deleted The authors would like to apologise for any inconvenience caused.
AB - The authors regret that incorrect information was given in the citation list of the publication The incorrect references and their corrections are as follows: Reference 27 should be same as reference 245 Reference 75 should be same as reference 82 Reference 274 should be same as reference 276 Reference 53 should be: Li, Q., Peng, X., Yang, H., Rodriguez, J. A., & Shu, Y. (2012). Contribution of organic cation transporter 3 to cisplatin cytotoxicity in human cervical cancer cells. Journal of pharmaceutical sciences, 101(1), 394–404. Reference 61 Should be: Waalkes, M. P., Liu, J., Kasprzak, K. S., & Diwan, B. A. (2006). Hypersusceptibility to cisplatin carcinogenicity in metallothionein-I/II double knockout mice: Production of hepatocellular carcinoma at clinically relevant doses. International journal of cancer, 119(1), 28–32. https://doi.org/10.1002/ijc.21245 References 69, and 73 should be: Wang, N., Hou, M. S., Zhan, Y., Shen, X. B., & Xue, H. Y. (2018). MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway. European Review for Medical & Pharmacological Sciences, 22(22). Reference 96 should be: Chen SH, Chang JY. New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment. Int J Mol Sci. 2019 Aug 24;20(17):4136. doi: 10.3390/ijms20174136 Reference 229 should be: O′Brien, J., Hayder, H., Zayed, Y., & Peng, C. (2018). Overview of microRNA biogenesis, mechanisms of actions, and circulation. Frontiers in endocrinology, 9, 402. Reference 247 should be: Schräder, M., Nayeri, S., Kahlen, J. P., Müller, K. M., & Carlberg, C. (1995). Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation. Molecular and cellular biology, 15(3), 1154–1161. References 4, 156, 180, 199, 270, 273, are unnecessary and can be deleted The authors would like to apologise for any inconvenience caused.
UR - http://www.scopus.com/inward/record.url?scp=85197460291&partnerID=8YFLogxK
U2 - 10.1016/j.biopha.2024.117097
DO - 10.1016/j.biopha.2024.117097
M3 - Comment/debate
AN - SCOPUS:85197460291
SN - 0753-3322
VL - 177
JO - Biomedicine and Pharmacotherapy
JF - Biomedicine and Pharmacotherapy
M1 - 117097
ER -